Anti-neuroinflammatory effects of alkaloid-enriched extract from Huperzia serrata on lipopolysaccharide-stimulated BV-2 microglial cells

Abstract

Context Alkaloid-enriched extract of Huperzia serrata (Thunb.) Trevis (Lycopodiaceae) (HsAE) can potentially be used to manage neuronal disorders. Objective This study determines the anti-neuroinflammatory effects of HsAE on lipopolysaccharide (LPS)-stimulated BV-2 microglial cells and the underlying mechanisms. Materials and methods BV-2 cells were pre- or post-treated with different concentrations of HsAE (25-150 µg/mL) for 30 min before or after LPS induction. Cell viability was assessed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay and no cytotoxicity was found. Nitric oxide (NO) concentration was determined using Griess reagent. The levels of prostaglandin E2 (PGE2), tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 were determined using enzyme-linked immunosorbent assay. The levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2 and the phosphorylation of mitogen-activated protein kinase (MAPK) were analyzed using western blotting. Results HsAE reduced LPS-induced NO production with half-maximal inhibitory concentration values of 99.79 and 92.40 µg/mL at pre- and post-treatment, respectively. Pre-treatment with HsAE at concentrations of 50, 100, and 150 µg/mL completely inhibited the secretion of PGE2, TNF-α, IL-6, and IL-1β compared to post-treatment with HsAE. This suggests that prophylactic treatment is better than post-inflammation treatment. HsAE decreased the expression levels of iNOS and COX-2 and attenuated the secretion of pro-inflammatory factors by downregulating the phosphorylation of p38 and extracellular signal-regulated protein kinase in the MAPK signaling pathway. Discussion and Conclusions HsAE exerts anti-neuroinflammatory effects on LPS-stimulated BV-2 cells, suggesting that it may be a potential candidate for the treatment of neuroinflammation in neurodegenerative diseases.

Effects of fatty acid‐ethanol amine (FA‐EA) derivatives on lipid accumulation and inflammation

“…In vitro inhibition effect of tested compounds ( L1 – L10) against nitric oxide (a), IL‐1β (b), TNF‐α (c) and IL‐6 (d) production by LPS‐induced RAW 264.7 cells by synthetic compound L1 – L10 . RAW 264.7 cells were pretreated with or without compounds (10 μM) for 1 h, and then cultured in the presence or absence of LPS (1 μg/mL) for 24 h. The NO levels in the medium were determined by the Griess assay (Dang et al, 2023). The inflammatory genes expression of IL‐1β, TNF‐α, and IL‐6 were determined by RT‐qPCR.…”

Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer’s Disease

“…Additionally, huperzine A may interact with the nicotinic acetylcholine receptors (α7nAChRs and α4β2nAChRs) to reduce IL-1β, TNF-α expression and block the signal transduction of NF-κB, thereby inhibiting the transcription of inflammatory mediators and producing an effective anti-inflammatory effect [ 103 ]. The alkaloid-rich extract of Huperzia serrata can effectively inhibit the release of NO and inflammatory cytokines and the expression of iNOS and COX-2 by regulating the MAPK pathway in LPS-stimulated BV-2 microglia cells [ 104 ]. Huperzine A has been found to be an effective and reversible AChEI with the permeability of BBB [ 105 ].…”

Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression

“…Huperzine A is a cholinesterase inhibitor, a medication that works by boosting neurotransmitter levels in the brain [ 95 ]. Huperzine A has been shown to improve memory and protect nerve cells, potentially slowing cognitive decline in Alzheimer's patients.…”